Table 1.
Patient A | Patient B | Patient C | ||||
---|---|---|---|---|---|---|
Component | 66h | 216 h | 264 h | 48 h | 72h | Mean |
Urine | ||||||
Total protein, mg/l | 410 | 1,520 | 1,030 | 710 | 1,120 | 958 |
Albumin (LX20), mg/l | 35 | 15 | 6 | 7 | 11 | 15 |
Albumin (Wako), mg/l | 23 | 33 | 19 | 16 | 22 | 23 |
Albumin (HPLC), mg/l | 1 | 604 | 320 | 325 | 443 | 402 |
α1-acid glycoprotein | ND | 220 | 120 | 210 | 250 | 160 |
α1-microglobulin | ND | 266 | 155 | 79 | 149 | 130 |
Retinol-binding prot., mg/l | ND | 0.4 | 0.6 | 11.9 | 7.9 | 4.2 |
Cystatin C, mg/l | ND | 29 | 7 | 5 | 15 | 11 |
Creatinine, g/l | 2.0 | 0.9 | 0.5 | 1.8 | 2.0 | 1.4 |
Plasma | ||||||
Albumin, g/l | 22 | 15 | 15 | 17 | 17 | 17 |
Specimens were selected for high ratio of albumin by HPLC versus immunoassay methods ( >10). Time of collection following hospital admission is indicated. ND indicates not determined. Plasma albumin at the time of urine collection also is indicated.